FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Suker, Mustafa, MD, Beumer, Berend R, Sadot, Eran, MD, Marthey, Lysiane, MD, Faris, Jason E, MD, Mellon, Eric A, MD, El-Rayes, Bassel F, Prof, Wang-Gillam, Andrea, MD, Lacy, Jill, Prof, Hosein, Peter J, MD, Moorcraft, Sing Yu, MD, Conroy, Thierry, Prof, Hohla, Florian, MD, Allen, Peter, MD, Taieb, Julien, Prof, Hong, Theodore S, MD, Shridhar, Ravi, MD, Chau, Ian, MD, van Eijck, Casper H, Prof, Koerkamp, Bas Groot, Dr
Published in The lancet oncology (01.06.2016)
Published in The lancet oncology (01.06.2016)
Get full text
Journal Article
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Fuchs, Charles S, Dr Prof, Tomasek, Jiri, MD, Yong, Cho Jae, Prof, Dumitru, Filip, MD, Passalacqua, Rodolfo, MD, Goswami, Chanchal, Prof, Safran, Howard, Prof, dos Santos, Lucas Vieira, MD, Aprile, Giuseppe, MD, Ferry, David R, Prof, Melichar, Bohuslav, Prof, Tehfe, Mustapha, MD, Topuzov, Eldar, Prof, Zalcberg, John Raymond, Prof, Chau, Ian, MD, Campbell, William, Prof, Sivanandan, Choondal, MD, Pikiel, Joanna, MD, Koshiji, Minori, MD, Hsu, Yanzhi, PhD, Liepa, Astra M, PharmD, Gao, Ling, PhD, Schwartz, Jonathan D, MD, Tabernero, Josep, MD
Published in The Lancet (British edition) (04.01.2014)
Published in The Lancet (British edition) (04.01.2014)
Get full text
Journal Article
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
Ready, Neal, Farago, Anna F., de Braud, Filippo, Atmaca, Akin, Hellmann, Matthew D., Schneider, Jeffrey G., Spigel, David R., Moreno, Victor, Chau, Ian, Hann, Christine L., Eder, Joseph Paul, Steele, Nicola L., Pieters, Anne, Fairchild, Justin, Antonia, Scott J.
Published in Journal of thoracic oncology (01.02.2019)
Published in Journal of thoracic oncology (01.02.2019)
Get full text
Journal Article
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
Antonia, Scott J, Prof, López-Martin, José A, MD, Bendell, Johanna, MD, Ott, Patrick A, MD, Taylor, Matthew, MD, Eder, Joseph Paul, MD, Jäger, Dirk, MD, Pietanza, M Catherine, MD, Le, Dung T, MD, de Braud, Filippo, Prof, Morse, Michael A, Prof, Ascierto, Paolo A, MD, Horn, Leora, MD, Amin, Asim, MD, Pillai, Rathi N, MD, Evans, Jeffry, Prof, Chau, Ian, MD, Bono, Petri, MD, Atmaca, Akin, MD, Sharma, Padmanee, Prof, Harbison, Christopher T, PhD, Lin, Chen-Sheng, PhD, Christensen, Olaf, MD, Calvo, Emiliano, Dr
Published in The lancet oncology (01.07.2016)
Published in The lancet oncology (01.07.2016)
Get full text
Journal Article
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
Fuchs, Charles S., Özgüroğlu, Mustafa, Bang, Yung-Jue, Di Bartolomeo, Maria, Mandala, Mario, Ryu, Min-Hee, Fornaro, Lorenzo, Olesinski, Tomasz, Caglevic, Christian, Chung, Hyun C., Muro, Kei, Van Cutsem, Eric, Elme, Anneli, Thuss-Patience, Peter, Chau, Ian, Ohtsu, Atsushi, Bhagia, Pooja, Wang, Anran, Shih, Chie-Schin, Shitara, Kohei
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.01.2022)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.01.2022)
Get full text
Journal Article
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer
Woolston, Andrew, Khan, Khurum, Spain, Georgia, Barber, Louise J., Griffiths, Beatrice, Gonzalez-Exposito, Reyes, Hornsteiner, Lisa, Punta, Marco, Patil, Yatish, Newey, Alice, Mansukhani, Sonia, Davies, Matthew N., Furness, Andrew, Sclafani, Francesco, Peckitt, Clare, Jiménez, Mirta, Kouvelakis, Kyriakos, Ranftl, Romana, Begum, Ruwaida, Rana, Isma, Thomas, Janet, Bryant, Annette, Quezada, Sergio, Wotherspoon, Andrew, Khan, Nasir, Fotiadis, Nikolaos, Marafioti, Teresa, Powles, Thomas, Lise, Stefano, Calvo, Fernando, Guettler, Sebastian, von Loga, Katharina, Rao, Sheela, Watkins, David, Starling, Naureen, Chau, Ian, Sadanandam, Anguraj, Cunningham, David, Gerlinger, Marco
Published in Cancer cell (08.07.2019)
Published in Cancer cell (08.07.2019)
Get full text
Journal Article
Targeting the human EGFR family in esophagogastric cancer
Chau, Ian, Okines, Alicia, Cunningham, David
Published in Nature reviews. Clinical oncology (01.08.2011)
Published in Nature reviews. Clinical oncology (01.08.2011)
Get full text
Journal Article
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Waddell, Tom, MBBCh, Chau, Ian, MD, Cunningham, David, Prof, Gonzalez, David, PhD, Okines, Alicia Frances Clare, MBBCh, Wotherspoon, Andrew, MBBCh, Saffery, Claire, Middleton, Gary, MD, Wadsley, Jonathan, MBBCh, Ferry, David, Prof, Mansoor, Wasat, PhD, Crosby, Tom, MBBS, Coxon, Fareeda, MBBS, Smith, David, MD, Waters, Justin, PhD, Iveson, Timothy, MD, Falk, Stephen, MD, Slater, Sarah, MD, Peckitt, Clare, MSc, Barbachano, Yolanda, PhD
Published in The lancet oncology (01.05.2013)
Published in The lancet oncology (01.05.2013)
Get full text
Journal Article
Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial
Herbst, Roy S, Prof, Arkenau, Hendrik-Tobias, MD, Santana-Davila, Rafael, MD, Calvo, Emiliano, MD, Paz-Ares, Luis, Prof, Cassier, Philippe A, MD, Bendell, Johanna, MD, Penel, Nicolas, Prof, Krebs, Matthew G, MD, Martin-Liberal, Juan, MD, Isambert, Nicolas, MD, Soriano, Andres, MD, Wermke, Martin, MD, Cultrera, Jennifer, MD, Gao, Ling, PhD, Widau, Ryan C, PhD, Mi, Gu, PhD, Jin, Jin, PhD, Ferry, David, MD, Fuchs, Charles S, Prof, Petrylak, Daniel P, Prof, Chau, Ian, MD
Published in The lancet oncology (01.08.2019)
Published in The lancet oncology (01.08.2019)
Get full text
Journal Article
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
Zhu, Andrew X, Dr, Park, Joon Oh, MD, Ryoo, Baek-Yeol, MD, Yen, Chia-Jui, MD, Poon, Ronnie, MD, Pastorelli, Davide, MD, Blanc, Jean-Frederic, MD, Chung, Hyun Cheol, MD, Baron, Ari D, MD, Pfiffer, Tulio Eduardo Flesch, MD, Okusaka, Takuji, MD, Kubackova, Katerina, MD, Trojan, Jorg, MD, Sastre, Javier, PhD, Chau, Ian, MD, Chang, Shao-Chun, MD, Abada, Paolo B, MD, Yang, Ling, MS, Schwartz, Jonathan D, MD, Kudo, Masatoshi, MD
Published in The lancet oncology (01.07.2015)
Published in The lancet oncology (01.07.2015)
Get full text
Journal Article
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial
Chua, Yu Jo, FRACP, Barbachano, Yolanda, PhD, Cunningham, David, Prof, Oates, Jacqui R, Brown, Gina, MD, Wotherspoon, Andrew, MRCPath, Tait, Diana, MD, Massey, Alison, Dip Onc, Tebbutt, Niall C, PhD, Chau, Ian, MD
Published in The lancet oncology (01.03.2010)
Published in The lancet oncology (01.03.2010)
Get full text
Journal Article
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
Ford, Hugo E R, Dr, Marshall, Andrea, PhD, Bridgewater, John A, PhD, Janowitz, Tobias, PhD, Coxon, Fareeda Y, MRCP, Wadsley, Jonathan, FRCR, Mansoor, Wasat, PhD, Fyfe, David, MD, Madhusudan, Srinivasan, FRCP, Middleton, Gary W, Prof, Swinson, Daniel, MD, Falk, Stephen, MD, Chau, Ian, MD, Cunningham, David, Prof, Kareclas, Paula, PhD, Cook, Natalie, PhD, Blazeby, Jane M, Prof, Dunn, Janet A, Prof
Published in The lancet oncology (2014)
Published in The lancet oncology (2014)
Get full text
Journal Article
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
Chao, Joseph, Fuchs, Charles S, Shitara, Kohei, Tabernero, Josep, Muro, Kei, Van Cutsem, Eric, Bang, Yung-Jue, De Vita, Ferdinando, Landers, Gregory, Yen, Chia-Jui, Chau, Ian, Elme, Anneli, Lee, Jeeyun, Özgüroglu, Mustafa, Catenacci, Daniel, Yoon, Harry H, Chen, Erluo, Adelberg, David, Shih, Chie-Schin, Shah, Sukrut, Bhagia, Pooja, Wainberg, Zev A
Published in JAMA oncology (01.06.2021)
Published in JAMA oncology (01.06.2021)
Get more information
Journal Article
Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)
DEWDNEY, Alice, CUNNINGHAM, David, YU JO CHUA, WONG, Rachel, BARBACHANO, Yolanda, OATES, Jacqueline, CHAU, Ian, TABERNERO, Josep, CAPDEVILA, Jaume, GLIMELIUS, Bengt, CERVANTES, Andres, TAIT, Diana, BROWN, Gina, WOTHERSPOON, Andrew, DE CASTRO, David Gonzalez
Published in Journal of clinical oncology (10.05.2012)
Published in Journal of clinical oncology (10.05.2012)
Get full text
Journal Article
MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer
Khakoo, Shelize, Carter, Paul David, Brown, Gina, Valeri, Nicola, Picchia, Simona, Bali, Maria Antonietta, Shaikh, Ridwan, Jones, Thomas, Begum, Ruwaida, Rana, Isma, Wotherspoon, Andrew, Terlizzo, Monica, von Loga, Katharina, Kalaitzaki, Eleftheria, Saffery, Claire, Watkins, David, Tait, Diana, Chau, Ian, Starling, Naureen, Hubank, Michael, Cunningham, David
Published in Clinical cancer research (01.01.2020)
Published in Clinical cancer research (01.01.2020)
Get full text
Journal Article